• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常白蛋白尿型糖尿病肾病:肾小管损伤与中性粒细胞明胶酶相关脂质运载蛋白。

"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.

机构信息

Department of Internal Medicine, University of Messina, Messina, Italy,

出版信息

Acta Diabetol. 2013 Dec;50(6):935-42. doi: 10.1007/s00592-013-0485-7. Epub 2013 Jun 11.

DOI:10.1007/s00592-013-0485-7
PMID:23754672
Abstract

The aim of this study was to demonstrate that neutrophil gelatinase-associated lipocalin (NGAL) increased before the onset of microalbuminuria in patients with type 1 diabetes mellitus (T1DM), representing an important biochemical parameter with high sensitivity and specificity to make a precocious diagnosis of "normoalbuminuric" diabetic nephropathy (DN). Serum NGAL (sNGAL) and urinary NGAL (uNGAL) levels were evaluated in a cohort of fifty patients affected by T1DM. They had no signs of clinical nephropathy. Thirty-five healthy subjects (HS) were recruited. sNGAL levels were significantly higher compared with those measured in HS [193.7 (103.2-405.4) vs. 46.4 (39.8-56.2) ng/ml; p < 0.0001], as were uNGAL levels [25.5 (14.2-40.2) vs. 6.5 (2.9-8.5) ng/ml; p < 0.0001]. sNGAL was found to be directly correlated with glycated hemoglobin. uNGAL also positively correlated with albuminuria, whereas an inverse correlation was found with uric acid. After multivariate analysis, significance was maintained for the correlation between uNGAL and microalbuminuria. In ROC analysis, sNGAL showed a good diagnostic profile such as uNGAL. NGAL increases in patients with T1DM, even before diagnosis of microalbuminuria representing an early biomarker of "normoalbuminuric" DN with a good sensitivity and specificity. NGAL measurement could be useful for the evaluation of early renal involvement in the course of diabetes.

摘要

本研究旨在证明,1 型糖尿病(T1DM)患者的中性粒细胞明胶酶相关脂质运载蛋白(NGAL)在微量白蛋白尿之前升高,这代表了一种具有高灵敏度和特异性的重要生化参数,可以对“正常白蛋白尿”糖尿病肾病(DN)进行早期诊断。在 50 名 T1DM 患者的队列中评估了血清 NGAL(sNGAL)和尿 NGAL(uNGAL)水平。他们没有临床肾病的迹象。招募了 35 名健康受试者(HS)。sNGAL 水平明显高于 HS 测量值[193.7(103.2-405.4)vs.46.4(39.8-56.2)ng/ml;p<0.0001],uNGAL 水平也明显升高[25.5(14.2-40.2)vs.6.5(2.9-8.5)ng/ml;p<0.0001]。sNGAL 与糖化血红蛋白呈直接相关。uNGAL 也与蛋白尿呈正相关,而与尿酸呈负相关。多变量分析后,uNGAL 与微量白蛋白尿之间的相关性仍然具有统计学意义。在 ROC 分析中,sNGAL 显示出与 uNGAL 相似的良好诊断特征。T1DM 患者的 NGAL 升高,甚至在微量白蛋白尿之前就升高,代表“正常白蛋白尿”DN 的早期生物标志物,具有良好的灵敏度和特异性。NGAL 测量可能有助于评估糖尿病病程中肾脏的早期受累情况。

相似文献

1
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.正常白蛋白尿型糖尿病肾病:肾小管损伤与中性粒细胞明胶酶相关脂质运载蛋白。
Acta Diabetol. 2013 Dec;50(6):935-42. doi: 10.1007/s00592-013-0485-7. Epub 2013 Jun 11.
2
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.中性粒细胞明胶酶相关载脂蛋白作为糖尿病肾病的早期生物标志物。
Kidney Blood Press Res. 2009;32(2):91-8. doi: 10.1159/000209379. Epub 2009 Mar 24.
3
Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.在正常白蛋白尿的儿童糖尿病肾病中检测早期肾小管病变
Iran J Kidney Dis. 2015 Mar;9(2):126-31.
4
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.中性粒细胞明胶酶相关脂质运载蛋白 (NGAL) 和肾损伤分子 1 (KIM1) 在糖尿病肾病患者中的作用:一项横断面研究及赖诺普利的影响。
Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.
5
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.中性粒细胞明胶酶相关脂质运载蛋白反映了慢性肾脏病患者肾功能损害的严重程度。
Kidney Blood Press Res. 2008;31(4):255-8. doi: 10.1159/000143726. Epub 2008 Jul 5.
6
Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.非白蛋白尿性蛋白尿作为 2 型糖尿病肾病早期小管损伤的生物标志物。
Diabetes Metab Res Rev. 2014 Nov;30(8):736-41. doi: 10.1002/dmrr.2546.
7
Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents.正常白蛋白尿、血压正常的1型糖尿病青少年中性粒细胞明胶酶相关脂质运载蛋白的评估
J Pediatr Endocrinol Metab. 2012;25(5-6):517-23.
8
Neutrophil Gelatinase-Associated Lipocalin as an Early Sign of Diabetic Kidney Injury in Children.中性粒细胞明胶酶相关脂质运载蛋白作为儿童糖尿病肾损伤的早期指标
J Clin Res Pediatr Endocrinol. 2015 Dec;7(4):274-9. doi: 10.4274/jcrpe.2002.
9
Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.中性粒细胞明胶酶相关脂质运载蛋白在修订的慢性肾脏病分类中的临床应用
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7172-81. eCollection 2014.
10
Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise.剧烈运动后血清和尿中性粒细胞明胶酶相关脂质运载蛋白(NGAL)的变化。
Clin Chem Lab Med. 2012 Feb 14;50(9):1585-9. doi: 10.1515/cclm-2011-0954.

引用本文的文献

1
Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.西格玛-1受体作为糖尿病肾病的新型治疗靶点
Int J Mol Sci. 2024 Dec 12;25(24):13327. doi: 10.3390/ijms252413327.
2
Identifying the Potential Diagnostic Gene Biomarkers and Forecasting the Potential Therapeutic Agents for Advanced Diabetic Nephropathy Based on Pyroptosis and Ferroptosis.基于细胞焦亡和铁死亡识别晚期糖尿病肾病的潜在诊断基因生物标志物并预测潜在治疗药物
J Inflamm Res. 2024 Aug 29;17:5763-5779. doi: 10.2147/JIR.S467388. eCollection 2024.
3
The tubular damage markers: neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in newborns with exposure to maternal diabetes during pregnancy.
孕期暴露于母体糖尿病的新生儿中的肾小管损伤标志物:中性粒细胞明胶酶相关脂质运载蛋白和肾损伤分子-1
Arch Med Sci. 2020 May 18;20(3):762-768. doi: 10.5114/aoms.2020.95424. eCollection 2024.
4
Novel Biomarkers for the diagnosis of diabetic nephropathy.用于诊断糖尿病肾病的新型生物标志物。
Caspian J Intern Med. 2024 Summer;15(3):382-391. doi: 10.22088/cjim.15.3.382.
5
Identification of immune-associated biomarkers of diabetes nephropathy tubulointerstitial injury based on machine learning: a bioinformatics multi-chip integrated analysis.基于机器学习的糖尿病肾病肾小管间质损伤免疫相关生物标志物的鉴定:一项生物信息学多芯片综合分析
BioData Min. 2024 Jul 1;17(1):20. doi: 10.1186/s13040-024-00369-x.
6
Pathomechanisms of Diabetic Kidney Disease.糖尿病肾病的发病机制
J Clin Med. 2023 Nov 27;12(23):7349. doi: 10.3390/jcm12237349.
7
Re-understanding and focusing on normoalbuminuric diabetic kidney disease.重新认识并关注正常白蛋白尿的糖尿病肾脏疾病。
Front Endocrinol (Lausanne). 2022 Dec 2;13:1077929. doi: 10.3389/fendo.2022.1077929. eCollection 2022.
8
Novel biomarkers for diabetic kidney disease.糖尿病肾病的新型生物标志物
Kidney Res Clin Pract. 2022 Sep;41(Suppl 2):S46-S62. doi: 10.23876/j.krcp.22.084. Epub 2022 Sep 30.
9
Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases.糖尿病肾病治疗策略的新进展。
Int J Mol Sci. 2022 Sep 17;23(18):10882. doi: 10.3390/ijms231810882.
10
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.糖尿病肾病的病理生理机制及潜在生物标志物。
Diabetes Metab J. 2022 Mar;46(2):181-197. doi: 10.4093/dmj.2021.0329. Epub 2022 Mar 24.